Attached files
| file | filename |
|---|---|
| EX-10.10 - EX-10.10 - Adverum Biotechnologies, Inc. | advm-ex1010_819.htm |
| EX-32.1 - EX-32.1 - Adverum Biotechnologies, Inc. | advm-ex321_7.htm |
| EX-31.2 - EX-31.2 - Adverum Biotechnologies, Inc. | advm-ex312_8.htm |
| EX-31.1 - EX-31.1 - Adverum Biotechnologies, Inc. | advm-ex311_6.htm |
| EX-21.1 - EX-21.1 - Adverum Biotechnologies, Inc. | advm-ex211_13.htm |
| EX-10.43 - EX-10.43 - Adverum Biotechnologies, Inc. | advm-ex1043_1145.htm |
| EX-10.36 - EX-10.36 - Adverum Biotechnologies, Inc. | advm-ex1036_1088.htm |
| EX-10.30 - EX-10.30 - Adverum Biotechnologies, Inc. | advm-ex1030_1090.htm |
| EX-10.17 - EX-10.17 - Adverum Biotechnologies, Inc. | advm-ex1017_1084.htm |
| EX-10.16 - EX-10.16 - Adverum Biotechnologies, Inc. | advm-ex1016_1089.htm |
| EX-10.14 - EX-10.14 - Adverum Biotechnologies, Inc. | advm-ex1014_1087.htm |
| EX-10.13 - EX-10.13 - Adverum Biotechnologies, Inc. | advm-ex1013_1085.htm |
| 10-K - 10-K - Adverum Biotechnologies, Inc. | advm-10k_20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 333-219890 on Form S-3 and S-3/A and No. 333-220894, No. 333-218465, No. 333-211439, No. 333-203398, and No. 333-199296 on Form S-8 of our report dated March 6, 2017, relating to the consolidated financial statements of Adverum Biotechnologies, Inc. and its subsidiaries appearing in this Annual Report on Form 10-K of Adverum Biotechnologies, Inc. for the year ended December 31, 2017.
/s/ Deloitte & Touche LLP
San Jose, California
March 6, 2018